{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:11:02Z","timestamp":1793387462792,"version":"4.5.0"},"reference-count":36,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T00:00:00Z","timestamp":1639353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100015904","name":"Alexander Mosley Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015904","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Incorporating 3,4-methylenedioxymethamphetamine (MDMA) as an adjunct to psychotherapy has shown promise in recent years for treating various mental health conditions, particularly those involving trauma. However, concerns about declines in mood and cognition during the days following dosing, also known as \u2018Blue Mondays\u2019, have been raised as limitations to its clinical use. Although these changes have been well-documented among recreational users, there are critical confounds to these reports that limit generalizability to clinically administered MDMA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>Here, we aimed to evaluate the evidence basis for the negative side effects associated with MDMA as well as inform our understanding of the drug\u2019s post-acute effects in a clinical context with an open-label study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The current open-label study examined MDMA therapy for alcohol use disorder (AUD; N = 14) and measured mood, sleep quality, illicit MDMA consumption and anecdotal reports after the acute drug effects had worn off.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Participants maintained a positive mood during the week following drug administration in a clinical context. Relative to baseline, self-reported sleep quality improved at the 3- and 6-month follow-ups. Finally, no participants reported using or desiring to use illicit MDMA, and the anecdotal reports indicated that they perceived the treatment favourably.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The results support the overall safety and tolerability of clinically administered MDMA and, importantly, suggest that the \u2018come downs\u2019 previously associated with the substance may be explained by confounds in research relating to the illicit sourcing of the drug and specific environmental setting for recreational consumption.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/02698811211055809","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T07:02:04Z","timestamp":1639378924000},"page":"360-367","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":18,"title":["Debunking the myth of \u2018Blue Mondays\u2019: No evidence of affect drop after taking clinical MDMA"],"prefix":"10.1177","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1212-6060","authenticated-orcid":false,"given":"Ben","family":"Sessa","sequence":"first","affiliation":[{"name":"Centre for Neuropsychopharmacology, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0578-8530","authenticated-orcid":false,"given":"Jacob S","family":"Aday","sequence":"additional","affiliation":[{"name":"Department of Psychology, Central Michigan University, Mount Pleasant, MI, USA"},{"name":"Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA, USA"},{"name":"DrugScience, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"Centre for Neuropsychopharmacology, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H Valerie","family":"Curran","sequence":"additional","affiliation":[{"name":"Research Department of Clinical, Educational & Health Psychology, University College London, London, UK"},{"name":"National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Measham","sequence":"additional","affiliation":[{"name":"Department of Sociology, Social Policy and Criminology, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Higbed","sequence":"additional","affiliation":[{"name":"Centre for Neuropsychopharmacology, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Nutt","sequence":"additional","affiliation":[{"name":"Centre for Neuropsychopharmacology, Imperial College London, London, UK"},{"name":"DrugScience, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,12,13]]},"reference":[{"key":"bibr1-02698811211055809","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3999(02)00330-6"},{"key":"bibr2-02698811211055809","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0322-6"},{"key":"bibr3-02698811211055809","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-019-0402-z"},{"key":"bibr4-02698811211055809","doi-asserted-by":"publisher","DOI":"10.1177\/0269881120926673"},{"key":"bibr5-02698811211055809","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2013.12.015"},{"key":"bibr6-02698811211055809","first-page":"821","volume":"92","author":"Curran HV","year":"1997","journal-title":"Addiction"},{"key":"bibr7-02698811211055809","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-0255-5"},{"key":"bibr8-02698811211055809","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211015221"},{"key":"bibr9-02698811211055809","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2002.10399952"},{"key":"bibr10-02698811211055809","volume-title":"Annual Report 2020","author":"Drugs Information Monitoring System (DIMS)","year":"2021"},{"key":"bibr11-02698811211055809","doi-asserted-by":"publisher","DOI":"10.1007\/978-90-481-2448-0_24"},{"key":"bibr12-02698811211055809","doi-asserted-by":"publisher","DOI":"10.1093\/geronb\/52B.4.P167"},{"key":"bibr13-02698811211055809","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-020-00803-8"},{"key":"bibr14-02698811211055809","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-020-05548-2"},{"key":"bibr15-02698811211055809","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-019-0446-0"},{"key":"bibr16-02698811211055809","doi-asserted-by":"publisher","DOI":"10.1177\/00914509211009901"},{"key":"bibr17-02698811211055809","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2018.11.001"},{"key":"bibr18-02698811211055809","doi-asserted-by":"publisher","DOI":"10.4337\/9781788117067.00030"},{"key":"bibr19-02698811211055809","volume-title":"Dancing on Drugs: Risk, Health and Hedonism in the British Club Scene","author":"Measham F","year":"2001"},{"key":"bibr20-02698811211055809","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01336-3"},{"key":"bibr21-02698811211055809","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(18)30135-4"},{"key":"bibr22-02698811211055809","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050714"},{"key":"bibr23-02698811211055809","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2015.1128580"},{"key":"bibr24-02698811211055809","doi-asserted-by":"publisher","DOI":"10.1126\/science.4023719"},{"key":"bibr25-02698811211055809","doi-asserted-by":"publisher","DOI":"10.1126\/science.1074501"},{"key":"bibr26-02698811211055809","unstructured":"Safer Party (2021) Takeshi 69 test results. Available at: https:\/\/www.saferparty.ch\/231.html"},{"key":"bibr27-02698811211055809","first-page":"43","volume-title":"Advances in Psychedelic Medicine: State-of-the-Art Therapeutic Applications","author":"Sessa B","year":"2019"},{"key":"bibr28-02698811211055809","doi-asserted-by":"publisher","DOI":"10.1177\/0269881107084738"},{"key":"bibr29-02698811211055809","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.114.152751"},{"key":"bibr30-02698811211055809","doi-asserted-by":"publisher","DOI":"10.1177\/0269881121991792"},{"key":"bibr31-02698811211055809","volume-title":"The Secret Chief Revealed: Conversations with a Pioneer of the Underground Therapy Movement","author":"Stolaroff M","year":"2004"},{"key":"bibr32-02698811211055809","doi-asserted-by":"publisher","DOI":"10.1016\/S1469-0292(01)00035-8"},{"key":"bibr33-02698811211055809","doi-asserted-by":"publisher","DOI":"10.1016\/j.alcohol.2014.07.019"},{"key":"bibr34-02698811211055809","doi-asserted-by":"publisher","DOI":"10.1002\/hup.529"},{"key":"bibr35-02698811211055809","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1395197"},{"key":"bibr36-02698811211055809","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75706-1"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811211055809","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02698811211055809","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811211055809","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:10:42Z","timestamp":1777507842000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02698811211055809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,13]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1177\/02698811211055809"],"URL":"https:\/\/doi.org\/10.1177\/02698811211055809","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,13]]}}}